Establishing an auxin-inducible GFP nanobody-based acute protein knockdown system to mimic hypomorphic mutations during early medaka embryogenesis
Preprint
Abstract
Creating hypomorphic mutations are crucial to study gene function in vivo , especially when null mutations result in (embryonic) lethality. This is especially the case for enzymes involved in glycosylation that, when mutated in human patients, are causing the disease congenital disorders of glycosylation (CDG). To resemble the patient conditions, it would be ideal to acutely modulate the proteins in question to directly interfere with protein levels of such essential enzymes. These methods offer to establish pathogenic enzyme levels resembling net enzyme activity reported from patients suffering from CDG, with Phosphomannomutase 2 - CDG (PMM2-CDG) as the most common form. We established an auxin-inducible acute protein knockdown system for the use in the teleost fish medaka ( Oryzias latipes ) by combining an improved degron (AID2) technology with a mAID-nanobody targeting endogenously GFP-tagged Pmm2 protein. We generated a fishline expressing a functional Pmm2-GFP fusion protein, by single copy integration of GFP into the pmm2 locus. Upon induction, the degron system efficiently reduced Pmm2-GFP levels and enzyme activity, recapitulating the activity level of the hypomorphic mutations associated with PMM2-CDG in patients. This broadly applicable approach enables the investigation of CDG disease mechanisms during early embryonic development through reduction of protein abundance mimicking hypomorphic mutations and thus substantially expands the range of the genetic toolbox. Summary Statement: The combination of TIR1F74G and mAID-GFP-nanobody enables efficient acute knockdown of endogenously GFP-tagged proteins in medaka. This approach successfully reduced Pmm2 enzyme activity to pathological levels as seen in PMM2-CDG patients.Keywords
All Related Versions
- Published version: Biology Open, 14 (11).
Funding Information
- European Research Council (ERC-SyG H2020, 810172)
This publication has 28 references indexed in Scilit:
- AAV-based gene replacement therapy prevents and halts manifestation of abnormal neurological phenotypes in a novel mouse model of PMM2-CDGGene Therapy, 2025
- Clinical and biochemical footprints of congenital disorders of glycosylation: Proposed nosologyMolecular Genetics and Metabolism, 2024
- deGradFP: A System to Knockdown GFP-Tagged Proteins2016
- Rapid Protein Depletion in Human Cells by Auxin-Inducible Degron Tagging with Short Homology DonorsCell Reports, 2016
- Lack of phosphomannomutase 2 affects Xenopus laevis morphogenesis and the non‐canonical Wnt5a/Ror2 signallingJournal of Inherited Metabolic Disease, 2015
- Mannose metabolism: More than meets the eyeBiochemical and Biophysical Research Communications, 2014
- Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in miceNature Medicine, 2011
- Fluorescent fusion protein knockout mediated by anti-GFP nanobodyNature Structural & Molecular Biology, 2011
- An auxin-based degron system for the rapid depletion of proteins in nonplant cellsNature Methods, 2009
- Medaka — a model organism from the far eastNature Reviews Genetics, 2002